Iii Capital Management Dexcom Inc Call Options Transaction History

Iii Capital Management

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $15,297 - $29,900	225 Added 300.0%	300 $11,000
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $7,056 - $9,765	75 New	75 $225,000
Q4 2021 Feb 15, 2022	SELL	$129.87 - $162.82 $9,740 - $12,211	-75 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$106.71 - $143.18 $8,003 - $10,738	75 New	75 $251,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Iii Capital Management, based on Form 13F filings with the SEC.

Stay updated on Iii Capital Management with notifications on news.